| P2093 | author name string | Huang P | |
| | Fiers W | |
| | Brouckaert P | |
| | Cauwels A | |
| | Everaerdt B | |
| | Van Molle W | |
| | Janssen B | |
| P2860 | cites work | Differential effects of nonselective nitric oxide synthase (NOS) and selective inducible NOS inhibition on hepatic necrosis, apoptosis, ICAM-1 expression, and neutrophil accumulation during endotoxemia | Q74088499 |
| | Clinical applications of TNF-alpha in cancer | Q77485569 |
| | Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine | Q22306067 |
| | Cyclic guanosine monophosphate as a mediator of vasodilation | Q24623087 |
| | Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids | Q29616817 |
| | The late phase of ischemic preconditioning is abrogated by targeted disruption of the inducible NO synthase gene | Q30454405 |
| | NG-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: implications for the involvement of nitric oxide | Q33575382 |
| | Mammalian nitric oxide synthases | Q33631306 |
| | Nitric oxide in septic shock | Q33631375 |
| | Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death | Q33795136 |
| | Inducible nitric oxide synthase is an endogenous neuroprotectant after traumatic brain injury in rats and mice | Q33857899 |
| | Shock and tissue injury induced by recombinant human cachectin | Q34189904 |
| | A circulating myocardial depressant substance in humans with septic shock. Septic shock patients with a reduced ejection fraction have a circulating factor that depresses in vitro myocardial cell performance | Q34560402 |
| | The multiple organ dysfunction syndrome caused by endotoxin in the rat: attenuation of liver dysfunction by inhibitors of nitric oxide synthase | Q35873190 |
| | N omega-amino-L-arginine, an inhibitor of nitric oxide synthase, raises vascular resistance but increases mortality rates in awake canines challenged with endotoxin | Q36231861 |
| | Protection by alpha 1-acid glycoprotein against tumor necrosis factor-induced lethality | Q36363851 |
| | Inhibition of NF-kappaB DNA binding by nitric oxide | Q39716552 |
| | Nitric oxide-mediated cyclooxygenase activation. A key event in the antiplatelet effects of nitrovasodilators | Q39765589 |
| | Role of nitric oxide in the regulation of myocardial function | Q40418244 |
| | Nitric oxide and apoptosis: another paradigm for the double-edged role of nitric oxide | Q41688613 |
| | The physiologic basis for anticytokine clinical trials in the treatment of sepsis | Q41724667 |
| | Activation of distinct cAMP-dependent and cGMP-dependent pathways by nitric oxide in cardiac myocytes | Q42472045 |
| | Hypertension in mice lacking the gene for endothelial nitric oxide synthase | Q42478091 |
| | Suppression of apoptosis by nitric oxide via inhibition of interleukin-1beta-converting enzyme (ICE)-like and cysteine protease protein (CPP)-32-like proteases | Q42947736 |
| | Involvement and dual effects of nitric oxide in septic shock | Q43743453 |
| | Methylene blue reverses endotoxin-induced hypotension | Q43869067 |
| | Inhibition of nitric oxide synthesis reduces the hypotension induced by bacterial lipopolysaccharides in the rat in vivo | Q44121526 |
| | Nitroxides increase the detectable amount of nitric oxide released from endothelial cells | Q46953280 |
| | Effects of tumor necrosis factor gene polymorphisms on patients with congestive heart failure. VEST Investigators for TNF Genotype Analysis. Vesnarinone Survival Trial | Q47870923 |
| | Selective inhibition of the activity of inducible nitric oxide synthase prevents the circulatory failure, but not the organ injury/dysfunction, caused by endotoxin | Q48001412 |
| | Use of methylene blue in patients with refractory septic shock: impact on hemodynamics and gas exchange. | Q50520996 |
| | Methylene blue--a promising treatment modality in sepsis induced by bowel perforation. | Q50531905 |
| | Effect of methylene blue on refractory neonatal hypotension. | Q50533734 |
| | Methylene blue administration in septic shock: a clinical trial. | Q50764693 |
| | Effects of methylene blue on blood pressure and reactivity to norepinephrine in endotoxemic rats. | Q50782634 |
| | Methylene blue increases systemic vascular resistance in human septic shock. Preliminary observations | Q50797195 |
| | Normalization of blood pressure and renal vascular resistance in SHR with a membrane-permeable superoxide dismutase mimetic: role of nitric oxide. | Q54130783 |
| | In vivo anti-tumour activity of recombinant human and murine TNF, alone and in combination with murine IFN-gamma, on a syngeneic murine melanoma. | Q54419516 |
| | Sphingosine Mediates the Immediate Negative Inotropic Effects of Tumor Necrosis Factor-α in the Adult Mammalian Cardiac Myocyte | Q59192165 |
| | Inhibition of vascular smooth muscle relaxation by LY83583. | Q64943566 |
| | Negative inotropic effects of cytokines on the heart mediated by nitric oxide | Q68208763 |
| | Systemic and hemodynamic effects of recombinant tumor necrosis factor alpha in isolation perfusion of the limbs | Q72129771 |
| | Use of selective and nonselective nitric oxide synthase inhibitors in rat endotoxemia: effects on hepatic morphology and function | Q73854506 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | TNF | Q18032037 |
| P304 | page(s) | 223-231 | |
| P577 | publication date | 2000-08-01 | |
| P1433 | published in | Immunity | Q6005457 |
| P1476 | title | Protection against TNF-induced lethal shock by soluble guanylate cyclase inhibition requires functional inducible nitric oxide synthase | |
| P478 | volume | 13 | |